- 12:23 27.11.2008, CT scans rival invasive heart tests. Miller Julie MD Johns Hopkins University School Medicine Baltimore Published in the New England Journal of Medicine, November 28,2008.
- CT scans of the heart or non-invasive imaging has been found to be equally as good as coronary angiograms and has the following advantages. First of all it is safer. 25 patients die each
- 13:59 26.11.2008, Migraine's association with Falling Estrogen Seams to Lower Breast Cancer Risk: Cancer Epidemiology, bio markers, and prevention
- A study showing that a history of migraine is associated with a lower risk of breast cancer is receiving a lot of press attention. Researches pooled data from 2 studies of postmenopausal
- 18:02 25.11.2008, Most Americans with Prediabetes don't now they have it CDC survey in MMWR Weekly review from the CDC
- Roughly 25% of the U.S population is estimated to have pre diabetes (impaired fasting glucose, impaired glucose tolerance or both).Only 4% report having it,
- 14:23 03.11.2008, Prebiotics may improve gut health, immune system foundation, UK conference hears.
- A prebiotic supplement consisting of simple sugars, produced from lactose, chicory and citrus fruit has been found to improve gut health,
- 14:22 03.11.2008, UK conference discusses disastrous impact of the myth of "HIV heath tourism"
- The UK government's policy of charging so-called "health tourists" for HIV treatment care is a public health disaster based on myth not fact,
- 14:21 03.11.2008, Bevirimat: good results at 400 mg liquid dose, but formulation problems persist: from Nam
- Phase 2 trials of the HIV maturation inhibitor Bevirimat continue to show good short-term safely and, at adequate doses in patients without key pre-existing HIV mutations,
- 14:20 03.11.2008, Continued Antiretroviral therapy reduces bone mineral density in smart study From Nam
- A sub-study of the Smart trial has bound greater losses of bone mineral density in people who stayed on continuous Antiretroviral therapy,
- 14:18 03.11.2008, Raltegravir nob-inferior to efavirinz: 48 week, phase 3 results
- Presented at the 48th intersceince Conference on antimicrobial Agents and Chemotherapy in Washington DC
- 14:14 03.11.2008, Darunavir effective and tolerable in treatment experienced children and adolescents at 48 weeks
- From the 48th Inter science Conference on Antimicrobial Agents and Chemotherapy in Washington
- 14:08 03.11.2008, Start treatment at CD4 cell counts below 500, says large cohort study Kithara, North American Aids Coors Collaboration on Research and design From Nam
- According to an analysis of data from a very large North Amercing cohort collaboration, starting Antiretroviral therapy
- Archives